By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Iroko Pharmaceuticals 

Philadelphia  Pennsylvania    U.S.A.
Phone: Fax:



Company News
Iroko Pharmaceuticals Signs New Strategic Agreement With Landsteiner Scientific To Bring ZORVOLEX® To Mexico 10/21/2014 7:04:28 AM
Iroko Pharmaceuticals Announces Inclusion Of ZORVOLEX® In Key 2015 National Formularies 9/3/2014 11:02:54 AM
Iroko Pharmaceuticals Gains FDA Approval Of ZORVOLEX® For Management Of Osteoarthritis Pain 8/25/2014 8:13:26 AM
Iroko Pharmaceuticals Continues To Expand Commercialization Of ZORVOLEX Ex-US 7/22/2014 7:50:13 AM
Iroko Pharmaceuticals Announces New Strategic Agreement To Commercialize ZORVOLEX® In Brazil 7/15/2014 7:47:16 AM
Iroko Pharmaceuticals Announces First International Filing for ZORVOLEX® 7/8/2014 6:59:46 AM
Iroko Pharmaceuticals Release: SoluMatrix® Meloxicam Demonstrates Significant Efficacy At 30 Percent Lower Doses In The Treatment Of Osteoarthritis 6/12/2014 9:40:19 AM
Iroko Pharmaceuticals Takes Low Dose Approach To Osteoarthritis Pain Meds To Avoid Adverse Events In Phase 3 Study 6/12/2014 5:49:55 AM
Iroko Pharmaceuticals Granted Key Patent For TIVORBEX™ 5/28/2014 10:14:25 AM
Iroko Pharmaceuticals To Present At The UBS 2014 Global Healthcare Conference 5/13/2014 7:35:26 AM